Radiotherapy provider Nucletron has appointed E. (Bert) H. de Groot as managing director. De Groot, who will continue in his current position as chairman of Nucletron's parent company Delft Instruments, replaces R.L.J. Scholte, who has left the company for personal reasons.
De Groot will assume Scholte's responsibilities until a permanent successor is named, according to the Veenendaal, Netherlands-based vendor.
By AuntMinnie.com staff writers
February 2, 2005
Related Reading
Nucletron shows new products at ASTRO, October 4, 2004
Nucletron previews new Oncentra module, August 17, 2004
MDS Nordion, Nucletron partner, June 29, 2004
Nucletron releases Oncentra 1.3, March 4, 2004
Nucletron gets 510(k) for Simulix Evolution, February 10, 2004
Copyright © 2005 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
